New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 1, 2014
HIGHER: Procter & Gamble (PG), up 2.2% after core EPS beat expectations, company announces plans to trim portfolio to 70-80 "core" brands... Expedia (EXPE), up 3.5% after upgraded at Raymond James following better than expected Q2 earnings results... Bally Technologies (BYI), up 31% after Scientific Games (SGMS) to acquire the company for $83.30 per share, or $5.1B. Scientific Games is up 13% after the news... Array BioPharma (ARRY), up 6% after receiving orphan status for ovarian cancer treatment... Tableau (DATA), up 4.5% after upgraded at Mizuho after better than expected Q2 earnings results. UP AFTER EARNINGS: LinkedIn (LNKD), up 8.6%... Arena Pharmaceuticals (ARNA), up 3.5%. DOWN AFTER EARNINGS: GoPro (GPRO), down 10.6%... SunPower (SPWR), down 3.1%... Pixelworks (PXLW), down 16.8%... YRC Worldwide (YRCW), up 15.8%. LOWER: (WWWW), down 25% after reporting second quarter results and acquiring U.K. online directory company Scoot... Hill International (HIL), down 12.9% after 8.5M share secondary offering priced at $4.25... Boyd Gaming (BYD), down 7.4% after downgraded at Credit Suisse following lower than expected Q2 earnings results... Galectin Therapeutics (GALT), down 4% after downgraded at Aegis... Biota (BOTA), down 33% after IGLOO did not achieve significant reduction in time to alleviation.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 >>
September 23, 2015
13:10 EDTGPROGoPro launches 360-degree videos on Facebook
GoPro (GPRO) announces it is bringing "immersive, spherical videos" to Facebook's (FB) News Feed. Beginning today, people on Facebook can experience GoPro 360-degree video directly through their web browser or Android mobile device, the action camera maker said in a press release. In the coming weeks, GoPro will launch additional 360-degree content on Facebook, it added. Shares of the action camera maker are up 10c to $33.41 in afternoon trading.
09:10 EDTGPROGoPro price target lowered to $60 from $76 at Cowen
Cowen lowered its Go Pro price target to $60 from $76, stating that the slower than expected start for the HERO4 Session now look well discounted. The firm also believes competitive concerns are overblown. Cowen reiterated its Outperform rating on GoPro shares.
09:02 EDTHILHill International project achieves substantial completion
Subscribe for More Information
September 22, 2015
16:15 EDTGPROGoPro CEO says does not believe Apple developing rival camera, Fortune reports
Subscribe for More Information
13:53 EDTGPROJPMorgan continues to recommend GoPro
Subscribe for More Information
12:55 EDTGPROGoPro CEO says 'lots of conversations' with Apple, none about takeover
Nick Goodman is speaking on CNBC.
12:54 EDTGPROGoPro CEO says market share has grown since Sony entered market
Subscribe for More Information
12:53 EDTGPROGoPro CEO says competitors like Sony have helped grow total reach
Subscribe for More Information
12:52 EDTGPROGoPro CEO says sales of Session camera improving
Nick Woodman is speaking on CNBC.
12:51 EDTGPROGoPro CEO says Session selling against incumbents
Subscribe for More Information
12:51 EDTGPROGoPro CEO says 'short-sighted' to call company 'one trick pony'
Subscribe for More Information
08:43 EDTEXPEExpedia price target raised to $150 from $135 at Cowen
Subscribe for More Information
05:22 EDTSPWRSunPower supplies solar panels for 12-MW Roc de Doun solar plant
Subscribe for More Information
September 21, 2015
16:53 EDTGPROOn The Fly: Top stock stories for Monday
Stocks on Wall Street began the session in positive territory and remained there for most of the morning. The Nasdaq was the first index to show signs of weakness after Hillary Clinton pledged to address the high cost of specialty drugs, sinking multiple biotech stocks. The averages later recovered from their afternoon lows, with both the Dow and S&P posting gains and the Nasdaq narrowly finishing in the green after Monday's drug pricing debate. ECONOMIC EVENTS: In the U.S., existing home sales fell 4.8% to a 5.31M rate in August, versus expectations for them to be down 1.6% to a rate of 5.5M. Over the weekend, three Federal Reserve officials, namely San Francisco Fed President John Williams, St. Louis Fed President James Bullard and Richmond Fed President Jeffrey Lacker, all argued that an interest-rate increase is still warranted this year. COMPANY NEWS: Biotech stocks declined after privately-held Turing Pharmaceuticals made headlines by enacting a 5,000% price increase on its treatment for toxoplasmosis, reigniting a debate around drug prices that previously embroiled costly Hepatitis C drugs including AbbVie's (ABBV) Viekira Pak and Gilead's (GILD) Sovaldi and Harvoni. Presidential candidate Hillary Clinton sent the debate to center stage by criticizing the "outrageous" prices of specialty drugs and promising to lay out a plan tomorrow to tackle "price gouging" in the specialty drug market. The NASDAQ Biotechnology index fell roughly 4.4% following the attention paid to Turing's drug and Clinton's response... Shares of Volkswagen (VLKAY) trading in New York dropped 17.1% to $30.10 after the EPA and California Air Resources Board detected manipulations that violate U.S. environmental standards while testing certain Volkswagen diesel cars. The EPA said Volkswagen may face civil penalties of $37,500 for each vehicle not in compliance with federal clean air rules, which could total as much as $18B, according to Reuters... Apple (AAPL), which has previously been reported to be working on an electric car via its "Project Titan," is speeding up those efforts and setting 2019 as a target to ship its first vehicle, according to The Wall Street Journal. Shares of Tesla Motors (TSLA) were volatile following the Journal's report, but closed the day up 1.37% at $264.20. MAJOR MOVERS: Among the notable gainers was Atmel (ATML), which surged 12.65%, to $8.19 after agreeing to be acquired by German chipmaker Dialog Semiconductor in a deal valued at roughly $4.6B. Also higher was Starwood Waypoint (SWAY), which gained $2.89, or 12.70%, to $25.64 after announcing a stock-for-stock merger agreement with Colony American Homes. Additionally, Pandora (P) rose 8.17% to $21.31 after receiving an interim opinion from the Register of Copyrights regarding the company's agreements with Merlin and Naxos. Among the noteworthy losers was GoPro (GPRO), which fell $2.88, or 8.19%, to $32.27 after Barron's contended that the company's stock could plunge another 30% to $25 as Apple, Sony (SNE), and others pressure the company's "one-hit wonder" products. Also lower was Mallinckrodt (MNK), which lost $8.23, or 10.02%, to $73.87 after ANI Pharma (ANIP) announced plans to acquire two new drug applications from Merck (MRK) that could compete with Acthar, Mallinckrodt's largest product. Separately, D.R. Horton (DHI) dipped 2.91% after the August U.S. existing home sales report showed a 4.8% drop for the month. Note also that Lennar (LEN) slipped 0.27% after its quarterly earnings report beat analyst estimates. INDEXES: The Dow rose 125.61, or 0.77%, to 16,510.19, the Nasdaq added 1.73, or 0.04%, to 4,828.96, and the S&P 500 gained 8.94, or 0.46%, to 1,966.97.
10:49 EDTGPROGoPro falls after Barron's predicts 'dramatic' drop in share price
GoPro (GPRO) shares fell in morning trading after an article from Barron's argued that the company's share price may drop to as low as $25. WHAT'S NEW: Alexander Eule argued in a Barron's article that GoPro's stock price may see a "dramatic" slip of as much as 30% to $25 due to significant competitive pressure from Apple (AAPL), Sony (SNE) and others. Eule noted that the company's shares have crashed to a recent $35 after peaking at $98 in October 2014 and even called the mostly bullish analyst views on the camera maker's stock "wishful thinking." Additionally, Eule called the company's cameras a "one-product wonder" and compares them to BlackBerry (BBRY) smartphones and Palm digital organizers, which previously dominated their respective markets. The article adds that there is risk in being overly bearish on the company, since the "impressive" brand might become an acquisition target. WHAT'S NOTABLE: Last Wednesday, Citi analyst Jeremy David said that GoPro chief financial officer Jack Lazar confirmed at the bank's Global Tech Conference the week before that the Hero4 Session camera has been off to a slow start since its launch on July 12. David said that the recent selloff in the company's shares has been motivated by investor concerns about the Session. At the time, Citi cut its third quarter fiscal 2015 estimate for the company to $425M from $438M and fourth quarter estimate to $560M from $737M, $148M below consensus estimate at the time of $708M. David also said he was reducing estimates for the second half of fiscal 2015 and first quarter of fiscal 2016 as a result of downside from the Hero4 Session, but left estimates after 1Q16 unchanged, saying the long-term fundamentals of the company are "intact." The analyst added that his firm was "humbled" by the recent move in share price and acknowledged that GoPro is the "quintessential product cycle stock," though he said he remains bullish on the long-term prospects of the camera maker and reiterated a $90 price target. David argued that GoPro missing Q3 estimates and guiding below the consensus for Q4 is largely priced in. Separately, The Wall Street Journal said on September 13 that shares of GoPro were starting to look like a bargain after dropping 50% in a month. The company had a difficult time selling its Hero4 Session camera in July in the face of competition from older GoPro models, the publication added. PRICE ACTION: In morning trading, GoPro shares are down 5.15% to $33.34. OTHERS TO WATCH: Ambarella (AMBA), which supplies chips to GoPro, is down 3.7% to $68.81.
10:15 EDTGPROGoPro fall sharply, levels to watch
Subscribe for More Information
10:00 EDTGALTOn The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: Aquinox (AQXP) initiated with an Outperform at Leerink... Callon Petroleum (CPE) initiated with a Sector Perform at RBC Capital... Constellium (CSTM) initiated with an Outperform at Cowen... Energy Focus (EFOI) initiated with an Outperform at Oppenheimer... Galectin Therapeutics (GALT) initiated with a Buy at H.C. Wainwright... Helix Energy (HLX) initiated with a Market Perform at Cowen... IPG Photonics (IPGP) initiated with a Buy at DA Davidson... Intrexon (XON) initiated with a Buy at Stifel... Micron (MU) initiated with an Overweight at Barclays... New Relic (NEWR) initiated with an Overweight at Pacific Crest... Rice Energy (RICE) initiated with a Buy at Jefferies... SanDisk (SNDK) initiated with an Equal Weight at Barclays... Simmons First National (SFNC) initiated with a Neutral at Piper Jaffray... South State (SSB) initiated with a Neutral at Piper Jaffray... TerraForm Global (GLBL) initiated with a Hold at Deutsche Bank... Trimble (TRMB) initiated with an Equal Weight at Morgan Stanley... inContact (SAAS) initiated with a Buy at Lake Street.
09:40 EDTGPROActive equity options trading on open
Active equity options trading on open: AAPL BAC ESV BABA FB NFLX TSLA TWTR GE GPRO JPM ONVO MU
08:45 EDTGPROOn The Fly: Pre-market Movers
HIGHER: Atmel (ATML), up 15% after agreeing to be acquired by Dialog Semiconductor in a deal valued at approximately $4.6B, or the equivalent of $10.42 per Atmel share... uniQure (QURE), up 12% after announcing topline results of one-year follow-up data from a Phase I/II clinical trial in four Sanfilippo B syndrome patients... lululemon (LULU), up 3% after the stock was upgraded to Overweight at Morgan Stanley... Alcobra (ADHD), up 15% after announcing that the FDA has granted Fast Track designation to Metadoxine Extended Release for the treatment of Fragile X Syndrome... Denbury Resources (DNR), up 5% after announcing that its board has decided to suspend the company's current 6.25c per share quarterly cash dividend and reinstated the ability for the company to repurchase shares under its previously authorized share repurchase program, which was suspended in late 2014... TherapeuticsMD (TXMD), up 4% after Jefferies analyst Chris Howerton more than doubled his price target for shares to $15 from $7, citing a positive view Vagicap in vulvovaginal atrophy. LOWER: GoPro (GPRO), down 4% after Barron's contended in an article this weekend that the stock may slip another 30% despite its recent pullback... Weatherford (WFT), down 7.7% after announcing the launch of concurrent underwritten public offerings of ordinary shares and mandatory exchangeable subordinated notes for an expected combined amount of $1B... ImmunoGen (IMGN), down 4.7% after Morgan Stanley downgraded the stock to Underweight, stating that consensus estimates for its key asset, IMGN 853, remain too optimistic on the potential success of an upcoming Phase II study.
07:02 EDTGALTGalectin Therapeutics initiated with a Buy at H.C. Wainwright
Target $7.
1 | 2 | 3 >>

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the disclaimer & terms of use